Literature DB >> 10705388

A mouse model of aerosol-transmitted orthopoxviral disease: morphology of experimental aerosol-transmitted orthopoxviral disease in a cowpox virus-BALB/c mouse system.

M J Martinez1, M P Bray, J W Huggins.   

Abstract

OBJECTIVES: To determine the morphologic changes and disease progression of aerosolized cowpox virus infection in BALB/c mice and to ascertain the suitability of cowpox virus-infected BALB/c mice as a model of aerosol-transmitted, orthopoxviral respiratory disease.
METHODS: BALB/c mice were inoculated with cowpox virus, Brighton strain, by aerosol or intranasal route. Mice were killed at specified times after inoculation, necropsied, and tissues were collected for routine histology, immunohistochemistry, and electron microscopy.
RESULTS: Inoculation by both routes resulted in disease and death. Immunolabeled viral antigen and lesions predominated in the tissues associated with the inoculation route, that is, lungs, airways, trachea, and nasal passages and sinuses. Tracheitis was evident in the intranasally infected group only. Lesions were generally necrotizing and hemorrhagic, neutrophilic, and increased in extent and severity in a time-dependent fashion. Viral intracytoplasmic inclusion bodies, immunolabeled viral antigen, or virions were readily seen in epithelial tissues, smooth muscle cells of airways and vessels, fibroblasts, periosteal cells, perineural cells, and macrophages. Although the extension of infection appeared to be primarily direct, lesions suggesting hematogenous dissemination were occasionally noted in bone marrow and skin. Transmission electron microscopy demonstrated features of cell injury or death, virion assembly and maturation, and both A-type and B-type inclusions.
CONCLUSIONS: Aerosol inoculation of BALB/c mice with cowpox virus provides a reliable and facilitative model of aerosol-transmitted, orthopoxviral respiratory disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10705388     DOI: 10.5858/2000-124-0362-AMMOAT

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  21 in total

1.  N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection.

Authors:  Meike S Gratz; Yasemin Suezer; Melanie Kremer; Asisa Volz; Monir Majzoub; Kay-Martin Hanschmann; Ulrich Kalinke; Astrid Schwantes; Gerd Sutter
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  Intrabronchial inoculation of cynomolgus macaques with cowpox virus.

Authors:  Alvin L Smith; Marisa St Claire; Srikanth Yellayi; Laura Bollinger; Peter B Jahrling; Jason Paragas; Joseph E Blaney; Reed F Johnson
Journal:  J Gen Virol       Date:  2011-09-21       Impact factor: 3.891

3.  What a Difference a Gene Makes: Identification of Virulence Factors of Cowpox Virus.

Authors:  Aistė Tamošiūnaitė; Saskia Weber; Timo Schippers; Annika Franke; Zhiyong Xu; Maria Jenckel; Florian Pfaff; Donata Hoffmann; Maegan Newell; B Karsten Tischer; Martin Beer; Nikolaus Osterrieder
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

4.  Deletion of major nonessential genomic regions in the vaccinia virus Lister strain enhances attenuation without altering vaccine efficacy in mice.

Authors:  Julie Dimier; Audrey Ferrier-Rembert; Karine Pradeau-Aubreton; Matthias Hebben; Danièle Spehner; Anne-Laure Favier; Danielle Gratier; Daniel Garin; Jean-Marc Crance; Robert Drillien
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

5.  Antivaccinia activities of acyclic nucleoside phosphonate derivatives in epithelial cells and organotypic cultures.

Authors:  R Snoeck; A Holý; C Dewolf-Peeters; J Van Den Oord; E De Clercq; G Andrei
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

6.  Differential pathogenesis of cowpox virus intranasal infections in mice induced by low and high inoculum volumes and effects of cidofovir treatment.

Authors:  Donald F Smee; Brian B Gowen; Miles K Wandersee; Min-Hui Wong; Ramona T Skirpstunas; Thomas J Baldwin; Justin D Hoopes; Robert W Sidwell
Journal:  Int J Antimicrob Agents       Date:  2008-02-21       Impact factor: 5.283

7.  Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice.

Authors:  Debra C Quenelle; Deborah J Collins; Earl R Kern
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

8.  Aerosolized cidofovir is retained in the respiratory tract and protects mice against intranasal cowpox virus challenge.

Authors:  Chad J Roy; Robert Baker; Kenneth Washburn; Mike Bray
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

9.  Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox.

Authors:  Peter B Jahrling; Lisa E Hensley; Mark J Martinez; James W Leduc; Kathleen H Rubins; David A Relman; John W Huggins
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-11       Impact factor: 11.205

10.  Effect of 5-iodo-2'-deoxyuridine on vaccinia virus (orthopoxvirus) infections in mice.

Authors:  Johan Neyts; Erik Verbeken; Erik De Clercq
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.